Male Hypogonadism Market - Company Profile (AbbVie Inc., Allergan plc, Astrazeneca plc, Bayer AG., Eli Lilly and Company Ltd., Endo International plc, Merck & Co., Inc., Ferring Holding S.A., Finox Biotech, IBSA Institut Biochimque SA, Laboratoires Genévrier S.A., and Teva Pharmaceutical Industries Ltd., are provided in the report. )and Competitive intelligence report 2017

TOC

Chapter: 1 COMPANY PROFILES

1.1. ABBVIE INC.

1.1.1. Company overview

1.1.2. Company snapshot

1.1.3. Operating business segments

1.1.4. Business performance

1.2. ALLERGAN, PLC

1.2.1. Company overview

1.2.2. Company snapshot

1.2.3. Operating business segments

1.2.4. Business performance

1.2.5. Key strategic moves and developments

1.3. ASTRAZENECA PLC.

1.3.1. Company overview

1.3.2. Company snapshot

1.3.3. Operating business segments

1.3.4. Business performance

1.4. BAYER AG

1.4.1. Company overview

1.4.2. Company snapshot

1.4.3. Operating business segment

1.4.4. Business performance

1.5. ELI LILLY AND COMPANY LIMITED

1.5.1. Company overview

1.5.2. Company snapshot

1.5.3. Operating business segments

1.5.4. Business performance

1.5.5. Key strategic moves and developments

1.6. ENDO INTERNATIONAL PLC.

1.6.1. Company overview

1.6.2. Company snapshot

1.6.3. Operating business segments

1.6.4. Business performance

1.6.5. Key strategic moves and developments

1.7. FERRING HOLDING S.A.

1.7.1. Company overview

1.7.2. Company snapshot

1.7.3. Operating business segments

1.7.4. Business performance

1.7.5. Key strategic moves and developments

1.8. FINOX BIOTECH (FINOX AG)

1.8.1. Company overview

1.8.2. Company snapshot

1.8.3. Operating business segments

1.8.4. Business performance

1.8.5. Key strategic moves and developments

1.9. IBSA INSTITUT BIOCHIMIQUE SA

1.9.1. Company overview

1.9.2. Company snapshot

1.9.3. Operating business segments

1.9.4. Business performance

1.10. LABORATOIRES GENEVRIER S.A.

1.10.1. Company overview

1.10.2. Company snapshot

1.10.3. Operating business segments

1.10.4. Business performance

1.10.5. Key strategic moves and developments

1.11. MERCK & CO., INC.

1.11.1. Company overview

1.11.2. Company snapshot

1.11.3. Operating business segments

1.11.4. Business performance

1.12. TEVA PHARMACEUTICAL INDUSTRIES LIMITED

1.12.1. Company overview

1.12.2. Company snapshot

1.12.3. Operating business segments

1.12.4. Business performance

1.12.5. Key strategic moves and developments

LIST OF TABLES AND FIGURES

TABLE 1. ABBVIE INC.: COMPANY SNAPSHOT

TABLE 2. ABBVIE INC.: OPERATING SEGMENTS

TABLE 3. ALLERGAN: COMPANY SNAPSHOT

TABLE 4. ALLERGAN: OPERATING SEGMENTS

TABLE 5. ASTRAZENECA PLC.: COMPANY SNAPSHOT

TABLE 6. ASTRAZENECA PLC.: OPERATING SEGMENTS

TABLE 7. BAYER: COMPANY SNAPSHOT

TABLE 8. BAYER: OPERATING SEGMENTS

TABLE 9. ELI LILLY AND COMPANY LIMITED: COMPANY SNAPSHOT

TABLE 10. ELI LILLY AND COMPANY LIMITED: OPERATING SEGMENTS

TABLE 11. ENDO INTERNATIONAL PLC.: COMPANY SNAPSHOT

TABLE 12. ENDO INTERNATIONAL PLC.: OPERATING SEGMENTS

TABLE 13. FERRING: COMPANY SNAPSHOT

TABLE 14. FERRING: OPERATING SEGMENTS

TABLE 15. FINOX AG: COMPANY SNAPSHOT

TABLE 16. FINOX AG: OPERATING SEGMENTS

TABLE 17. IBSA INSTITUT BIOCHIMIQUE SA: COMPANY SNAPSHOT

TABLE 18. IBSA INSTITUT BIOCHIMIQUE SA: OPERATING SEGMENTS

TABLE 19. LABORATOIRES GENÉVRIER: COMPANY SNAPSHOT

TABLE 20. LABORATOIRES GENÉVRIER: OPERATING SEGMENTS

TABLE 21. MERCK: COMPANY SNAPSHOT

TABLE 22. MERCK: OPERATING SEGMENTS

TABLE 23. TEVA PHARMACEUTICAL: COMPANY SNAPSHOT

TABLE 24. TEVA PHARMACEUTICAL: OPERATING SEGMENTS